Download Custom Antibody Information Form

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
CUSTOM ANTIBODY INFORMATION FORM
The information that you provide in this form is used for antigen design and service package recommendation.
Antigen design report and service agreement will be sent to you for your review before the project is started.
Please complete this form and return to [email protected]. The items with * are required. All the
information will be kept confidential.
I. CUSTOMER INFORMATION:
First name: *
Last Name: *
P.I. name and title :
Company/Institute/Organization: *
Shipping Information*
Address:
Postcode:
Country: Japan
email: *
Phone Number: *
How did you know about our offer: *
1.email 2.Visit 3.Meeting4.Referred by colleagues (Please specify):
II. PROTEIN INFORMATION
Protein UniProt /NCBI number and Name: *
Species: *
Full- length protein sequence: *
III. PROJECT INFORMATION
Antibody type: *
1.Monoclonal Antibody 2.Polyclonal Antibody
Application (please choose no more than two): *
1.ELISA 2.WB 3.IF 4.IHC 5.IP6.CHIP 7.FACS 8. Neutralization and Blocking9.NA
When will this project start: *
1.Immediately 2.Within 1 month 3.Within 3 months 4.More than 3 months later
Does this project require special animal treatment? *
1.AAALAC 2.PHS Assurance 3.NA
2This information will only be used for service package recommendation and will NOT change the
price of each service package.
IV. OPTIONAL INFORMATION FOR ANTIGEN DESIGN:
Confidential Document
Version 2013-07
1/3
Please note that the limits on the antigen design might increase the difficulty to generate a successful antibody a lot and
therefore result in a higher price.
1. The special regions/sequence patterns of target protein that should be recognized by this antibody:
a) List the amino acid sequences (region) that you PREFER to be used for antigen design
b) List the amino acid sequences (region) that you define ONLY to be used for antigen design
2. The special regions/sequence patterns of the target protein that should NOT be recognized by this
antibody:
1) Amino acid sequence :
2) Amino acid sequence :
3. This antibody should NOT recognize the following proteins (species):
1) Protein name:
Species:
Protein UniProt/NCBI number:
Full-length protein sequence:
2) Protein name:
Protein UniProt/NCBI number:
Full-length protein sequence:
Species:
4. Other special requests and information:
For better antigen design, you are highly appreciated to provide following information in the case you have
related experimental or published data. Otherwise we will use the data predicted by our software for the
project.
1) Post-translational modification sometimes influences the antibody binding and is hardly predicted by
software. Please indicate the positions if you know any (e.g. glycosylation, residue modifications etc.)
and Recognition by antibody --- Yes? No? (if customer don’t indicate the Yes or No, Abmart will exclude
the sequence information in antigen design)
Confidential Document
Version 2013-07
2/3
2) Signal peptide sequence( we will exclude this sequence in our design):
3) Trans-membrane domains( we will exclude this sequence in our design)
 The total numbers of trans-membrane domains:
 Amino acid region of trans-membrane domain:
4) Interaction sites with other molecules might influence the recognition of antibody. Please indicate the
position of the sites and the expectation of recognition by your antibody
Interaction sites:
Recognition by antibody --- Yes? No? NA?(if customer don’t indicate the Yes or No, Abmart will
exclude the sites information in antigen design)
Any other information you’d like to provide for better antigen design (for example protease cleavage
site) Recognition by antibody --- Yes? No? (if customer don’t indicate the Yes or No, Abmart will
exclude the sequence information in antigen design)
V. SERVICE PACKAGE RECOMMENDATION(FILLED BY SALES AGENT):
Confidential Document
Version 2013-07
3/3